Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Cannae Holdings Q1 2026 Earnings Call - Multi-Club Sports Strategy Drives Record EBITDA Amid Non-Core Asset Purge
Cannae Holdings is aggressively pivoting toward sports and entertainment assets, using proceeds from non-core divestments to fuel share buybacks and targeted investments. The pivot is anchored by Blac...
- Cannae returned $51 million to shareholders in Q1 2026, with 86% allocated to buybacks and dividends, up from 70% a year ago.
- The board expanded the share repurchase authorization by 14.9 million shares, reflecting confidence in the stock’s undervaluation relative to intrinsic value.
- Black Knight Football reported record EBITDA of $136 million for the 12 months ended December 2025, driven by a nearly four-fold increase in player trading profits.
- +7 more takeaways
Plug Power Inc Q1 2026 Earnings Call - Gross Margin Surges as Hydrogen Demand Accelerates
Plug Power delivered a pivotal first quarter for 2026, with revenue jumping 22% year-over-year to $163.5 million and gross margin dramatically improving from negative 55% to negative 13%. The company ...
- Revenue surged 22% year-over-year to $163.5 million, driven by strong traction across material handling, electrolyzers, and hydrogen fuel platforms.
- Gross margin improved 42 percentage points year-over-year, moving from negative 55% to negative 13%, signaling a structural inflection in unit economics.
- Electrolyzer revenue skyrocketed 343% to $40.8 million, fueled by commissioning milestones on major European projects and a $8 billion opportunity funnel.
- +7 more takeaways
Bakkt Holdings Q1 2026 Earnings Call - Bakkt Builds Regulated Stablecoin Infrastructure Ahead of U.S. Legislation
Bakkt Holdings entered its first quarter of 2026 as a focused, debt-free stablecoin infrastructure provider, having fully divested its legacy loyalty business. The company operates a clean, discipline...
- Bakkt operates a clean, debt-free balance sheet with $82.6 million in liquidity and a streamlined cost base of $18.6 million in controllable OpEx, stripped of legacy loyalty business expenses.
- The company frames the market as a structural shift where stablecoin infrastructure is cannibalizing legacy payment rails, with global stablecoin settlement volume reaching $33 trillion in 2025.
- U.S. regulatory tailwinds are building, with the GENIUS Act and CLARITY Act creating a federal framework for stablecoins and trading that favors Bakkt’s existing compliance and licensing footprint.
- +7 more takeaways
Power Solutions International Q1 2026 Earnings Call - Oil & Gas Weakness and Wisconsin Ramp-Up Weigh on Q1 Profits
Power Solutions International reported a rough first quarter, with net sales declining 5% year-over-year to $128.6 million as a prolonged slump in oil and gas demand collided with the messy economics ...
- Net sales declined 5% year-over-year to $128.6 million, driven by softness in the oil and gas sector and uneven customer ordering patterns for data center products.
- Gross margin contracted to 22.9% from 29.7% in the prior year, reflecting an unfavorable product mix and elevated production costs during the capacity ramp-up at the Wisconsin operation.
- Gross margin improved sequentially by approximately 100 basis points from the fourth quarter of 2025, signaling early progress in reducing operational inefficiencies at the Wisconsin facility.
- +7 more takeaways
SKYX Platforms Corp Q1 2026 Earnings Call - Record Revenue Growth and Strategic B2B Expansion
SKYX Platforms Corp. delivered a strong Q1 2026 performance, posting record revenue of $22 million, a 10% year-over-year increase, marking nine consecutive quarters of growth. The company’s cash posit...
- Record Q1 2026 revenue of $22 million, up 10% year-over-year, extending a nine-quarter growth streak.
- Cash position surged to over $32 million, up from $10 million at year-end 2025, supporting a 2026 cash flow positive target.
- Gross profit increased 16% to $7 million, with gross margins expanding to 30% from 28% in Q1 2025.
- +7 more takeaways
Halozyme Q1 2026 Earnings Call - ENHANZE Royalties Surge 43%, $1B Buyback, Hypercon Pipeline Accelerates
Halozyme delivered a powerful first quarter, with revenue jumping 42% year-over-year to $377 million and non-GAAP EPS rising 44% to $1.60. The growth was driven by a 43% surge in ENHANZE royalties to ...
- Revenue surged 42% year-over-year to $377 million in Q1 2026, driven by a 43% increase in ENHANZE royalties to $241 million.
- Non-GAAP EPS rose 44% to $1.60, and adjusted EBITDA grew 42% to $230 million, reflecting strong operating leverage.
- Management reaffirmed 2026-2028 guidance, projecting ENHANZE royalties to exceed $1 billion in 2026, representing 30-35% growth over 2025.
- +7 more takeaways
SI-BONE Q1 2026 Earnings Call - Raised Guidance on Strong Revenue Growth and Profitability Expansion
SI-BONE delivered a strong first quarter with worldwide revenue of $52.6 million, up 11.2% year-over-year, driven by robust demand for its iFuse platform and early momentum from new product launches. ...
- Worldwide revenue reached $52.6 million, up 11.2% year-over-year, with U.S. revenue at $49.3 million (+10%) and international revenue at $3.3 million (+34%).
- Full-year 2026 revenue guidance raised to $230–$233 million, implying 14–16% year-over-year growth, with expectations for quarterly acceleration.
- Gross margin held steady at 79.8%, with full-year guidance increased by 100 basis points to approximately 79%, driven by favorable procedure mix and operational efficiencies.
- +12 more takeaways
AlTi Global Q1 2026 Earnings Call - Revenue Growth Masks Expense Overhang
AlTi Global delivered a quarter defined by stark contrasts: revenue surged 28% to $73 million, driven by a strong acquisition and resilient recurring fees, yet the firm is grappling with a bloated cos...
- Total revenue rose 28% year-over-year to $73 million, fueled by strong growth in management fees and investment distributions.
- Recurring management and advisory fees increased 16% to $52 million, highlighting the stability of the firm's core business model.
- Assets under management grew 9% to $49 billion, driven by investment performance and the Kontora acquisition, despite market volatility.
- +7 more takeaways
LENZ Therapeutics Q1 2026 Earnings Call - VIZZ Launch Acceleration Efforts Outpace Early Script Growth
LENZ Therapeutics is in the early, high-friction phase of building a new presbyopia category with VIZZ, generating $1.9 million in Q1 revenue and 25,000 filled prescriptions. The company acknowledges ...
- Q1 net revenue reached $1.9 million, comprising $1.7 million in product sales and $250,000 in license revenue from international partnerships.
- Approximately 25,000 paid and filled prescriptions were generated in Q1, marking a 19% sequential increase from Q4.
- The company has onboarded over 10,000 unique prescribers in just two quarters, with VIZZ generating roughly 70% more scripts per prescriber than VUITY at a comparable stage.
- +7 more takeaways
Ceribell Q1 2026 Earnings Call - Record Account Growth and New Market Entries Signal Acceleration
Ceribell delivered a strong first quarter with revenue of $26.5 million, up 29% year-over-year, driven by record headband utilization and its largest quarter of net new account additions. The company ...
- Revenue of $26.5 million grew 29% year-over-year and 7% sequentially, driven by record headband utilization and record net new account additions.
- Ceribell added 33 net new hospital accounts in Q1, marking its strongest single quarter of account growth since becoming a public company.
- The company initiated the full commercial launch of its neonate and pediatric seizure monitoring products following successful 5-site pilots.
- +7 more takeaways